MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 19:58
MiMedx Group Debt to Equity Ratio : 0.0797 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0797 |
| March 31, 2026 | 0.0724 |
| December 31, 2025 | 0.0878 |
| September 30, 2025 | 0.0762 |
| June 30, 2025 | 0.0852 |
| March 31, 2025 | 0.092 |
| December 31, 2024 | 0.1286 |
| September 30, 2024 | 0.1051 |
| June 30, 2024 | 0.1146 |
| March 31, 2024 | 0.1249 |
| December 31, 2023 | 0.3542 |
| September 30, 2023 | 0.5219 |
| June 30, 2023 | 0.6118 |
| March 31, 2023 | 0.6535 |
| December 31, 2022 | 0.7043 |
| September 30, 2022 | 0.6643 |
| June 30, 2022 | 0.6129 |
| March 31, 2022 | 0.5671 |
| December 31, 2021 | 0.5757 |
| September 30, 2021 | 0.5539 |
| June 30, 2021 | 0.5612 |
| March 31, 2021 | 0.615 |
| December 31, 2020 | 0.567 |
| September 30, 2020 | 0.4729 |
| June 30, 2020 | 3.007 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.281 |
| December 31, 2019 | 2.028 |
| September 30, 2019 | 1.776 |
| June 30, 2019 | 2.707 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.0046 |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.0039 |
| September 30, 2017 | 0.0001 |
| June 30, 2017 | 0.0001 |
| March 31, 2017 | 0.0002 |
| December 31, 2016 | 0.0002 |
| September 30, 2016 | 0.0003 |
| June 30, 2016 | 0.0006 |
| March 31, 2016 | 0.0009 |
| December 31, 2015 | 0.0012 |
| September 30, 2015 | 0.0016 |
| June 30, 2015 | 0.0021 |
| March 31, 2015 | 0.0026 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0034 |
| June 30, 2014 | 0.0041 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1839 |
| Perspective Therapeutics, Inc. | 0.0122 |
| ABVC BioPharma, Inc. | 0.2807 |
| Enovis Corp. | 0.9269 |
| Edwards Lifesciences Corp. | 0.0663 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 281.00M |
| Total Liabilities (Quarterly) | 65.00M |
| Shareholders Equity (Quarterly) | 216.00M |
| Current Ratio | 5.334 |
| Net Debt Paydown Yield | 0.05% |